Clinical Trial Update: People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists

View source ↗

Summary

This clinical trial is evaluating the effects of combining ocrelizumab with GLP-1 receptor agonists in people with multiple sclerosis and is currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• GLP-1 receptor agonists
• Ocrelizumab (ocrelizumab)

Snippet

Sponsor: Northwestern University | Conditions: Multiple Sclerosis | Status: RECRUITING